1. Home
  2. EUDA vs NRSN Comparison

EUDA vs NRSN Comparison

Compare EUDA & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited

HOLD

Current Price

$13.62

Market Cap

31.0M

Sector

Finance

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.70

Market Cap

26.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EUDA
NRSN
Founded
2021
2017
Country
Singapore
Israel
Employees
123
16
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.0M
26.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EUDA
NRSN
Price
$13.62
$0.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$55.00
$8.50
AVG Volume (30 Days)
2.3K
170.2K
Earning Date
12-19-2023
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$134.73
N/A
Revenue Next Year
$195.03
$583.67
P/E Ratio
$123.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.63
52 Week High
$25.70
$2.10

Technical Indicators

Market Signals
Indicator
EUDA
NRSN
Relative Strength Index (RSI) 48.20 40.25
Support Level $1.20 $0.68
Resistance Level $15.36 $0.75
Average True Range (ATR) 0.85 0.04
MACD -0.09 0.00
Stochastic Oscillator 46.50 25.54

Price Performance

Historical Comparison
EUDA
NRSN

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: